RIL
AXSM icon

Rothschild Investment LLC’s Axsome Therapeutics AXSM Stock Holding History

Rothschild Investment LLC’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Hold
67
– – ﹤0.01% 1624
2026
Q1 		$11.3K Buy
67
+11
+20% +$1.9K ﹤0.01% 1634
2025
Q4 		$10.2K Sell
56
-4
-7% -$558 ﹤0.01% 1563
2025
Q3 		$7.29K Sell
60
-20
-25% -$2.25K ﹤0.01% 1561
2025
Q2 		$8.35K Buy
80
+20
+33% +$2.12K ﹤0.01% 1287
2025
Q1 		$7K Buy
60
+25
+71% +$2.85K ﹤0.01% 1289
2024
Q4 		$2.96K Sell
35
-5
-13% -$460 ﹤0.01% 1575
2024
Q3 		$3.6K Buy
40
+20
+100% +$1.75K ﹤0.01% 1420
2024
Q2 		$1.61K Buy
20
+15
+300% +$1.11K ﹤0.01% 1469
2024
Q1 		$399 Buy
+5
New +$420 ﹤0.01% 1444

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Rothschild Investment LLC's AXSM Position: Q2 2026 in Review

Rothschild Investment LLC held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 67 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Rothschild Investment LLC first reported a position in AXSM in Q1 2024 and has held it in 10 quarters since. 190 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Rothschild Investment LLC held 67 shares of Axsome Therapeutics worth $16.4K as of Q2 2026.
  • Rothschild Investment LLC left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1624 holding.
  • Rothschild Investment LLC first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 190 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.